Evidence map›Paper›PMID 37182881›Full record

ArticleJournal of Alzheimer's disease : JAD2023

Extracellular Tau Oligomers Damage the Axon Initial Segment.

Merci N Best, Yunu Lim, Nina N Ferenc, Nayoung Kim, Lia Min, Dora Bigler Wang, Kamyar Sharifi, Anna E Wasserman, Sloane A McTavish, Karsten H Siller and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. A network-level transport model of tau progression in the Alzheimer's brain.Mathematical medicine and biology : a journal of the IMA · 2025
    Article
  8. Review
  9. Cellular and pathological functions of tau.Nature reviews. Molecular cell biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Merci N BestDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Yunu LimDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Nina N FerencDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Nayoung KimDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Lia MinDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.
Dora Bigler WangDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Kamyar SharifiDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Anna E WassermanDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Sloane A McTavishDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Karsten H SillerResearch Computing, University of Virginia, Charlottesville, VA, USA.
Marieke K JonesClaude Moore Health Sciences Library, University of Virginia, Charlottesville, VA, USA.
Paul M JenkinsDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.
James W MandellDepartment of Pathology, University of Virginia, Charlottesville, VA, USA.
George S BloomDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
University of Virginia · USUniversity of Michigan · US

Funding

BIOTECHNOLOGY TRAINING PROGRAMT32GM008715 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LAURIE, GORDON WILLIAM · 2000 to 2019
$6.6M
NIGMS NIH HHS T32 GM008715
6 · The paper itself

Abstract

backgroundIn Alzheimer's disease (AD) brain, neuronal polarity and synaptic connectivity are compromised. A key structure for regulating polarity and functions of neurons is the axon initial segment (AIS), which segregates somatodendritic from axonal proteins and initiates action potentials. Toxic tau species, including extracellular oligomers (xcTauOs), spread tau pathology from neuron to neuron by a prion-like process, but few other cell biological effects of xcTauOs have been described.

objectiveTest the hypothesis that AIS structure is sensitive to xcTauOs.

methodsCultured wild type (WT) and tau knockout (KO) mouse cortical neurons were exposed to xcTauOs, and quantitative western blotting and immunofluorescence microscopy with anti-TRIM46 monitored effects on the AIS. The same methods were used to compare TRIM46 and two other resident AIS proteins in human hippocampal tissue obtained from AD and age-matched non-AD donors.

resultsWithout affecting total TRIM46 levels, xcTauOs reduce the concentration of TRIM46 within the AIS and cause AIS shortening in cultured WT, but not TKO neurons. Lentiviral-driven tau expression in tau KO neurons rescues AIS length sensitivity to xcTauOs. In human AD hippocampus, the overall protein levels of multiple resident AIS proteins are unchanged compared to non-AD brain, but TRIM46 concentration within the AIS and AIS length are reduced in neurons containing neurofibrillary tangles.

conclusionxcTauOs cause partial AIS damage in cultured neurons by a mechanism dependent on intracellular tau, thereby raising the possibility that the observed AIS reduction in AD neurons in vivo is caused by xcTauOs working in concert with endogenous neuronal tau.

Indexed as

Alzheimer DiseaseAxon Initial SegmentAnimalsAxonsHippocampusHumansMiceMice, KnockoutNeuronstau Proteinstau ProteinsAlzheimer’s diseaseankyrin-G proteinaxon initial segmentneurofascin proteintau proteinsTRIM46 protein

Identifiers

PMID37182881
PMCPMC10357156
OpenAlexW4376117315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.